Treace Medical director awarded 30,000 stock units

Treace Medical Concepts director Betsy Hanna received an equity award of 30,000 restricted stock units (RSUs).

Rhea-AI Filing Summary

Treace Medical Concepts director Betsy Hanna received an equity award of 30,000 restricted stock units (RSUs). Each RSU converts into one share of common stock and will vest 100% on the earlier of May 19, 2027 or the 2027 annual stockholder meeting, contingent on continued service. After this grant, she holds 75,243 shares, including the 30,000 RSUs, with settlement of these units deferred until a change in control or her separation of service.

Insider Trade Summary

Grant/Award: 30,000 shares

Grant/Award 1 txn

Insider Hanna Betsy

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	30,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 75,243 shares (Direct)

Footnotes (2)

1. F1. Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.
2. F2. Includes 30,000 restricted stock units.

Key Figures

RSU grant size: 30,000 RSUs Post-grant holdings: 75,243 shares Vesting schedule: 100% by May 19, 2027 +2 more

5 metrics

RSU grant size 30,000 RSUs Equity award to director on May 19, 2026

Post-grant holdings 75,243 shares Total holdings following RSU award, including units

Vesting schedule 100% by May 19, 2027 Or earlier 2027 annual stockholder meeting, if sooner

RSU-to-share ratio 1 RSU : 1 share Each RSU settles into one common share upon vesting

Deferral trigger events Change in control or separation Share delivery deferred until one of these events

Key Terms

restricted stock units (RSUs), change in control, separation of service

3 terms

restricted stock units (RSUs) financial

"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share..."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

change in control financial

"defer receipt of the shares ... until the earlier of a change in control or the Reporting Person's separation of service"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

separation of service financial

"until the earlier of a change in control or the Reporting Person's separation of service to the Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did TMCI director Betsy Hanna report?

Director Betsy Hanna reported an equity compensation grant of 30,000 restricted stock units in Treace Medical Concepts. These RSUs are not a market purchase; they are an award that converts into common shares upon future vesting and settlement.

How many Treace Medical (TMCI) RSUs were granted to the director?

The director received 30,000 restricted stock units from Treace Medical Concepts. Each RSU will convert into one share of common stock if and when the units vest and are ultimately settled under the award’s terms.

What is the vesting schedule for TMCI director Betsy Hanna’s 30,000 RSUs?

The 30,000 RSUs will vest 100% on the earlier of May 19, 2027 or the 2027 annual meeting of stockholders. Vesting is conditioned on Betsy Hanna continuing to provide service to Treace Medical Concepts through the applicable vesting date.

How many Treace Medical (TMCI) shares does the director hold after this RSU grant?

After the RSU grant, the director holds 75,243 shares of Treace Medical Concepts. This figure includes the 30,000 restricted stock units, which represent rights to receive an equal number of common shares upon vesting and settlement.

What deferral terms apply to TMCI director Betsy Hanna’s RSU award?

The director voluntarily deferred receipt of common shares issuable upon RSU settlement until the earlier of a change in control or her separation of service. This means shares underlying vested RSUs will not be delivered until one of those triggering events occurs.

Does this TMCI Form 4 reflect a stock purchase or a compensation award?

The Form 4 reflects a compensation-related award, not an open-market stock purchase. The 30,000 units are restricted stock units granted at no cash cost, which may eventually convert into common shares if vesting and settlement conditions are met.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 09:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hanna Betsy

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FLORIDA 32081

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		A		30,000(1)	A	$0	75,243(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.

2. Includes 30,000 restricted stock units.

	/s/ Lisa Taylor as Attorney-in-fact for Betsy Hanna	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)